With board appointments bolstering its development credentials. Genesis’s Ulysses project ticks the right boxes. The project still has room to grow prior to development. Our target price of $0.20 is at a subjective premium to our valuation, and we expect this subjective premium to be backfilled as capital and skills are attracted to organic and inorganic growth opportunities.
To access the full report please log in under the Client Area at the bottom of this page.
Argonaut’s Client Area allows you to view delayed share prices, access Argonaut’s wealth of Research as well as create custom portfolios and set up company watch lists.
If you would like to access our research please contact us to create an account.